Apparently so in some areas in the U.S., like New York and Minnesota.
The progressive Left is openly attempting to codify racial categories into education, culture, law—and now medicine. New York State has authorized health-care providers to include race in a set of risk factors to determine who qualifies for the limited quantity of life-saving Covid-19 treatments. New York City’s official guidance to providers also reads: “Longstanding systemic health and social inequities may contribute to an increased risk of getting sick and dying from COVID-19.” As a result, health-care providers in the city will now “consider race and ethnicity when assessing individual risk,” prioritizing nonwhite patients over their white counterparts.
[. . .]
Unfortunately, other states have begun to follow New York’s lead. Guidelines from Minnesota’s Department of Health now declare that medical facilities should use race as a factor in determining who receives the limited supplies of highly effective monoclonal antibody treatments. According to the document, those who are not of “BIPOC [black, indigenous, and people of color] status” will be “deprioritize[d].” Theoretically, an affluent Asian-American would enjoy priority over a poor Lebanese immigrant with roughly the same age and health condition.
[. . .]
The growing ideological capture of medicine is consistent with the Left’s efforts to establish race as a marker of a host of attributes such as societal victimization, moral worth, economic status, agency, health, and now Covid risk. As long as institutions continue to assign meaning to skin color, the quest to transcend racial divisions will never be realized.